Canada markets open in 9 hours 30 minutes

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.42+0.03 (+0.11%)
At close: 04:00PM EDT
27.67 +0.25 (+0.91%)
After hours: 06:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 12.38B
Enterprise Value 16.99B
Trailing P/E 15.39
Forward P/E 9.81
PEG Ratio (5 yr expected) 1.45
Price/Sales (ttm)7.35
Price/Book (mrq)1.91
Enterprise Value/Revenue 7.59
Enterprise Value/EBITDA 12.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3-14.81%
S&P500 52-Week Change 322.60%
52 Week High 333.86
52 Week Low 325.92
50-Day Moving Average 327.95
200-Day Moving Average 328.34

Share Statistics

Avg Vol (3 month) 32.69M
Avg Vol (10 day) 33.32M
Shares Outstanding 5452.11M
Implied Shares Outstanding 6597.44M
Float 8387.98M
% Held by Insiders 113.40%
% Held by Institutions 171.28%
Shares Short (May 15, 2024) 413.28M
Short Ratio (May 15, 2024) 44.69
Short % of Float (May 15, 2024) 43.06%
Short % of Shares Outstanding (May 15, 2024) 42.94%
Shares Short (prior month Apr 15, 2024) 414.15M

Dividends & Splits

Forward Annual Dividend Rate 40.84
Forward Annual Dividend Yield 43.07%
Trailing Annual Dividend Rate 30.81
Trailing Annual Dividend Yield 32.96%
5 Year Average Dividend Yield 4N/A
Payout Ratio 445.51%
Dividend Date 3Jun 14, 2024
Ex-Dividend Date 4May 16, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 35.69%
Operating Margin (ttm)-12.99%

Management Effectiveness

Return on Assets (ttm)3.54%
Return on Equity (ttm)12.06%

Income Statement

Revenue (ttm)2.24B
Revenue Per Share (ttm)4.99
Quarterly Revenue Growth (yoy)-17.00%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)798.86M
Diluted EPS (ttm)1.78
Quarterly Earnings Growth (yoy)-98.60%

Balance Sheet

Total Cash (mrq)872M
Total Cash Per Share (mrq)1.93
Total Debt (mrq)6.14B
Total Debt/Equity (mrq)62.24%
Current Ratio (mrq)12.52
Book Value Per Share (mrq)14.41

Cash Flow Statement

Operating Cash Flow (ttm)2.62B
Levered Free Cash Flow (ttm)-1.13B